Cap displayed in your preferred currency (USD)
Industries & Sectors
| Description | Symbol | Type | #Stocks | Cap (M) | 1Day %* | 1Wk %* | 1Mo %* | 3Mo %* | 6Mo %* | 1Yr %* |
|---|---|---|---|---|---|---|---|---|---|---|
| North America (Primary) | PRIMARYNOAM | Univ | 8,182 | 57,735,260 | 1.17% | 0.69% | -0.55% | 3.20% | 17.21% | 22.70% |
| Healthcare | HEALTHCARE | Sector | 1,343 | 6,388,469 | 0.29% | 1.41% | -0.56% | -1.12% | 15.27% | 9.49% |
| Biopharmaceuticals | BIOPHARMA | SubSec | 680 | 2,955,318 | 0.10% | 2.57% | -1.73% | -2.72% | 23.89% | 24.55% |
| System-Specific Biopharmaceuticals | BIOPHARMASYS | Industry | 308 | 1,511,979 | -0.59% | 2.10% | -2.46% | -2.28% | 20.73% | 10.62% |
| Neurology Biopharmaceuticals | NEUROLOGY | SubInd | 101 | 128,255 | 1.01% | 3.54% | -0.24% | -5.10% | 22.78% | -8.73% |
Show Stocks
Sort: 1Mo %
| Description | Symbol | Type | #Stocks | Cap (M) | 1Day %* | 1Wk %* | 1Mo %* | 3Mo %* | 6Mo %* | 1Yr %* |
|---|---|---|---|---|---|---|---|---|---|---|
| PTC Therapeutics, Inc. | PTCT:USAPTCT:USA | Stock | 1 | 2,530 | -1.81% | 15.54% | 18.66% | 31.67% | 82.68% | -40.91% |
| Edgewise Therapeutics, Inc. | EWTX:USAEWTX:USA | Stock | 1 | 1,375 | 1.19% | 20.72% | 18.16% | 4.05% | 197.11% | 104.83% |
| Longboard Pharmaceuticals, Inc. | LBPH:USALBPH:USA | Stock | 1 | 831 | -6.29% | 8.39% | 15.60% | 10.29% | 296.57% | 158.15% |
| Cassava Sciences, Inc. | SAVA:USASAVA:USA | Stock | 1 | 931 | -0.05% | -1.30% | 7.67% | -3.75% | -9.03% | -1.30% |
| Scholar Rock Holding Corp. | SRRK:USASRRK:USA | Stock | 1 | 1,166 | 1.66% | 5.64% | 6.60% | 0.39% | 22.41% | 108.28% |
| Sarepta Therapeutics, Inc. | SRPT:USASRPT:USA | Stock | 1 | 12,630 | 2.32% | 3.80% | 6.26% | 6.46% | 71.89% | 2.68% |
| GH Research PLC | GHRS:USAGHRS:USA | Stock | 1 | 608 | 4.38% | 11.13% | 5.99% | 54.09% | 65.44% | 34.41% |
| Biogen, Inc. | BIIB:USABIIB:USA | Stock | 1 | 31,669 | 1.87% | 4.12% | 5.95% | -10.06% | -10.07% | -30.63% |
| Xenon Pharmaceuticals, Inc. | XENE:USAXENE:USA | Stock | 1 | 3,297 | 1.74% | 8.02% | 3.65% | -5.69% | 32.30% | 5.78% |
| Axsome Therapeutics, Inc. | AXSM:USAAXSM:USA | Stock | 1 | 3,542 | 0.82% | 4.31% | 3.64% | -18.25% | 16.15% | 5.13% |
| Intra-Cellular Therapies, Inc. | ITCI:USAITCI:USA | Stock | 1 | 6,631 | -2.19% | -6.09% | 2.37% | -0.29% | 31.35% | 11.02% |
| Neurocrine Biosciences, Inc. | NBIX:USANBIX:USA | Stock | 1 | 14,155 | 0.63% | 3.47% | 2.25% | -0.67% | 24.09% | 46.82% |
| Harmony Biosciences Holdings, Inc. | HRMY:USAHRMY:USA | Stock | 1 | 1,793 | -0.38% | 7.67% | 1.09% | 4.12% | 28.18% | -11.20% |
| Cerevel Therapeutics Holdings, Inc. | CERE:USACERE:USA | Stock | 1 | 7,717 | -0.09% | 0.19% | 0.90% | 2.04% | 71.02% | 35.47% |
| Neurology Biopharmaceuticals | NEUROLOGY | SubInd | 101 | 128,255 | 1.01% | 3.54% | -0.24% | -5.10% | 22.78% | -8.73% |
| S&P 500 | SPY:USASPY:USA | Benchmark | 14,779 | 75,176,635 | 1.24% | 0.60% | -0.35% | 4.13% | 19.55% | 28.03% |
| Stoke Therapeutics, Inc. | STOK:USASTOK:USA | Stock | 1 | 552 | 2.82% | -3.14% | -1.23% | 169.51% | 191.75% | 12.13% |
| Dyne Therapeutics, Inc. | DYN:USADYN:USA | Stock | 1 | 2,271 | 0.31% | 5.46% | -1.40% | 19.20% | 264.76% | 115.54% |
| Prothena Corp. Plc | PRTA:USAPRTA:USA | Stock | 1 | 1,231 | 4.04% | 9.87% | -1.42% | -8.46% | -34.41% | -67.32% |
| Catalyst Pharmaceuticals, Inc. | CPRX:USACPRX:USA | Stock | 1 | 1,577 | -2.00% | -1.14% | -2.65% | 9.93% | 16.64% | -11.64% |
| Jazz Pharmaceuticals Plc | JAZZ:USAJAZZ:USA | Stock | 1 | 6,934 | 0.66% | 0.50% | -4.51% | -9.81% | -14.62% | -19.64% |
| ACADIA Pharmaceuticals, Inc. | ACAD:USAACAD:USA | Stock | 1 | 2,807 | -0.18% | 2.03% | -5.54% | -32.07% | -25.84% | -20.88% |
| Alkermes Plc | ALKS:USAALKS:USA | Stock | 1 | 4,069 | 0.80% | -2.55% | -6.82% | -8.90% | -0.44% | -14.87% |
| Supernus Pharmaceuticals, Inc. | SUPN:USASUPN:USA | Stock | 1 | 1,687 | 1.85% | 2.53% | -7.25% | 12.89% | 28.08% | -15.46% |
| Denali Therapeutics, Inc. | DNLI:USADNLI:USA | Stock | 1 | 2,372 | 1.96% | 11.08% | -9.74% | 8.28% | -12.51% | -35.27% |
| REGENXBIO, Inc. | RGNX:USARGNX:USA | Stock | 1 | 741 | 1.14% | 3.95% | -12.11% | 36.61% | 18.60% | -15.47% |
| SAGE Therapeutics, Inc. | SAGE:USASAGE:USA | Stock | 1 | 839 | 6.37% | 1.83% | -15.92% | -42.56% | -28.73% | -71.02% |
| Biohaven Ltd. | BHVN:USABHVN:USA | Stock | 1 | 3,301 | 1.98% | 4.41% | -22.24% | -13.72% | 37.98% | 196.14% |
| Neumora Therapeutics, Inc. | NMRA:USANMRA:USA | Stock | 1 | 1,469 | 0.33% | 1.09% | -32.63% | -39.06% | -15.29% | N/A |
* Colors indicate performance relative to the benchmark.